Shots: Grunenthal acquired Averitas Pharma in all stocks transaction, gained the commercialization rights for Qutenza The focus of the acquisition is to expand and strengthen its footprints in the markets […]readmore
Tags : Grunenthal
Shots: AZ will receive an upfront $700M & $115M plus milestone payments up to $90M & $17M for Nexium (esomeprazole) and Vimovo (naproxen/esomeprazole) respectively. Grunenthal to get commercialization rights for […]readmore